Items where authors include "Cummin, TE"

Article

Davies, A, Cummin, TE, Barrans, S et al. (21 more authors) (2019) Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial. The Lancet Oncology, 20 (5). pp. 649-662. ISSN 1470-2045